Lawrence C.

Lawrence C. has a diverse work experience in the pharmaceutical industry. Lawrence currently works at Amunix Pharmaceuticals as a Senior Scientist, a role they have held since April 2023. Prior to that, they worked as a Scientist III and Consultant at the same company.

Before joining Amunix Pharmaceuticals, Lawrence worked at Nektar Therapeutics as a Scientist from November 2018 to November 2019. Lawrence also worked at AbbVie as a Senior Scientist from February 2017 to September 2018.

Earlier in their career, Lawrence held positions at Igenica and OncoMed Pharmaceuticals as a Senior Research Associate, from January 2011 to October 2016 and from June 2007 to December 2010, respectively.

Lawrence's entry into the pharmaceutical industry began at Amgen, where they worked as an Associate Scientist from July 2004 to May 2007. At Amgen, they conducted in-depth characterization of the EAE mouse model and investigated the immune-modulatory potential of small molecule targets.

Prior to their industry experience, Lawrence worked at Roche as a Research Associate II from October 2001 to May 2004. Lawrence also worked at UC Davis as a Post-Graduate Researcher in the Department of Neurology, where they established and implemented an orthotopic in vivo rodent model for glial blastoma multiform and conducted research on tumor growth using various techniques.

Overall, Lawrence has a strong background in pharmaceutical research and has held various roles throughout their career in both industry and academic settings.

Lawrence C. has a Bachelor of Science (BS) degree in Biochemistry from the University of California, Davis. The dates of their enrollment and completion of the degree are not provided.